LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
14.12
+0.02 (0.14%)
Apr 1, 2025, 10:34 AM EDT - Market open
LENSAR Employees
LENSAR had 140 employees as of December 31, 2024. The number of employees increased by 10 or 7.69% compared to the previous year.
Employees
140
Change (1Y)
10
Growth (1Y)
7.69%
Revenue / Employee
$382,100
Profits / Employee
-$224,314
Market Cap
166.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LNSR News
- 5 days ago - LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR - Business Wire
- 4 weeks ago - LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025 - GlobeNewsWire
- 7 weeks ago - Medical Devices Firm Lensar Surges Ahead On Robotic Technology - Seeking Alpha
- 4 months ago - LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day - GlobeNewsWire
- 5 months ago - LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript - Seeking Alpha